Treace Medical Concepts's three largest insider shareholders as of June 18, 2026 are John T. Treace (Chief Executive Officer, 7.00Mn shares), John R Treace (Director, 1.82Mn shares), James T Treace (Director, 1.43Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| John K Bakewell | - | 174,056 | 0 | 21 May, 2025 |
| James T Treace | - | 0 | 1,428,946 | 24 Nov, 2021 |
| John R Treace | - | 0 | 1,822,790 | 11 May, 2022 |
| Thomas E Timbie | - | 0 | 1,149,069 | 17 Mar, 2023 |
| Richard W Mott | - | 1,096,861 | 0 | 21 May, 2025 |
| Lawrence W Hamilton | - | 44,056 | 0 | 21 May, 2025 |
| Jane E Kiernan | - | 63,949 | 0 | 21 May, 2025 |
| Lance A Berry | - | 44,593 | 0 | 21 May, 2025 |
| Mark Hair | Chief Financial Officer | 952,002 | 0 | 20 Apr, 2026 |
| Deepti Jain | - | 70,243 | 0 | 21 May, 2025 |
| Jaime A. Frias | Chief Legal Officer | 50,659 | 0 | 10 Mar, 2022 |
| Sean F. Scanlan | Chief Innovation Officer | 704,677 | 0 | 11 Mar, 2026 |
| John T. Treace | Chief Executive Officer | 7,004,550 | 0 | 11 Mar, 2026 |
| Joe W. Ferguson | Svp, Research Development | 419,756 | 0 | 08 Oct, 2021 |
| Daniel E. Owens | Chief Human Resources Officer | 30,914 | 0 | 17 Mar, 2023 |
| Aaron Berutti | Svp, Sales | 205,092 | 0 | 12 Aug, 2025 |
| Terry W. Lubben | Svp, Operations | 5,850 | 0 | 10 Mar, 2022 |
| Betsy Hanna | - | 45,243 | 0 | 21 May, 2025 |
| Scot Michael Elder | Chief Legl Comp Off, Corpsec | 794,936 | 0 | 11 Mar, 2026 |
| Gaetano Guglielmino | Chief Commercial Officer | 490,901 | 0 | 23 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 17 Apr, 2026 | Mark Hair | Common Stock | D | 11,547 | $0.00 | 952,002 | D | F |
| 01 Apr, 2026 | Mark Hair | Common Stock | A | 100,000 | $0.00 | 963,549 | D | A |
| 08 Mar, 2026 | Scot Michael Elder | Common Stock | D | 175 | $0.00 | 796,611 | D | F |
| 08 Mar, 2026 | John T. Treace | Common Stock | D | 2,062 | $0.00 | 7,009,571 | D | F |
| 08 Mar, 2026 | John T. Treace | Common Stock | D | 2,062 | $0.00 | 7,009,571 | D | F |
| 08 Mar, 2026 | Sean F. Scanlan | Common Stock | D | 401 | $0.00 | 706,073 | D | F |
| 08 Mar, 2026 | John T. Treace | Common Stock | D | 2,062 | $0.00 | 7,009,571 | D | F |
| 08 Mar, 2026 | Mark Hair | Common Stock | D | 964 | $0.00 | 867,244 | D | F |
| 10 Mar, 2026 | John T. Treace | Common Stock | D | 5,021 | $0.00 | 7,004,550 | D | F |
| 10 Mar, 2026 | John T. Treace | Common Stock | D | 5,021 | $0.00 | 7,004,550 | D | F |
| 10 Mar, 2026 | John T. Treace | Common Stock | D | 5,021 | $0.00 | 7,004,550 | D | F |
| 10 Mar, 2026 | Mark Hair | Common Stock | D | 3,695 | $0.00 | 863,549 | D | F |
| 10 Mar, 2026 | Scot Michael Elder | Common Stock | D | 1,675 | $0.00 | 794,936 | D | F |
| 10 Mar, 2026 | Sean F. Scanlan | Common Stock | D | 1,396 | $0.00 | 704,677 | D | F |
| 10 Feb, 2026 | Sean F. Scanlan | Common Stock | A | 16,875 | $1.05 | 706,474 | D | M |
| 10 Feb, 2026 | Sean F. Scanlan | Stock Option (Right to Buy) | D | 16,875 | $0.00 | 0 | D | M |
| 22 Jan, 2026 | John T. Treace | Common Stock | D | 14,254 | $0.00 | 6,761,633 | D | F |
| 21 Jan, 2026 | Sean F. Scanlan | Common Stock | A | 53,500 | $0.72 | 427,099 | D | M |
| 22 Jan, 2026 | John T. Treace | Common Stock | D | 14,254 | $0.00 | 6,761,633 | D | F |
| 22 Jan, 2026 | John T. Treace | Common Stock | D | 14,254 | $0.00 | 6,761,633 | D | F |